Experience With Pre-Dialysis Administration of Tobramycin in the Outpatient Setting.
作者信息
Tessier Jean-François, Ouellet Georges, Vallée Michel, Lafrance Jean-Philippe
机构信息
Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
出版信息
Can J Kidney Health Dis. 2022 Jul 16;9:20543581221112505. doi: 10.1177/20543581221112505. eCollection 2022.
Abstract
摘要
相似文献
1
Experience With Pre-Dialysis Administration of Tobramycin in the Outpatient Setting.门诊环境下妥布霉素透析前给药的经验
Can J Kidney Health Dis. 2022 Jul 16;9:20543581221112505. doi: 10.1177/20543581221112505. eCollection 2022.
2
Therapeutic Drug Monitoring of Inhaled Tobramycin in a Post-Hematopoietic Cell Transplant Patient With Bronchiolitis Obliterans and End-Stage Renal Disease.造血干细胞移植后患有闭塞性细支气管炎和终末期肾病患者吸入妥布霉素的治疗药物监测
J Pediatr Pharmacol Ther. 2020;25(5):451-454. doi: 10.5863/1551-6776-25.5.451.
3
Stability of tobramycin and ceftazidime in icodextrin peritoneal dialysis solution.妥布霉素和头孢他啶在艾考糊精腹膜透析液中的稳定性。
Perit Dial Int. 2009 Jan-Feb;29(1):52-7.
4
Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.腹膜透析对血清妥布霉素和克林霉素水平的影响。
Antimicrob Agents Chemother. 1975 Nov;8(5):574-80. doi: 10.1128/AAC.8.5.574.
5
Pharmacokinetics of tobramycin in patients with stable renal impairment, patients undergoing peritoneal dialysis, and patients on chronic hemodialysis.妥布霉素在肾功能稳定受损患者、接受腹膜透析患者及慢性血液透析患者中的药代动力学。
Antimicrob Agents Chemother. 1974 Jun;5(6):611-6. doi: 10.1128/AAC.5.6.611.
6
Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.接受自动化腹膜透析治疗的患者间歇性静脉注射头孢唑林和妥布霉素的药代动力学
J Am Soc Nephrol. 2000 Jul;11(7):1310-1316. doi: 10.1681/ASN.V1171310.
7
Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen.
Clin J Am Soc Nephrol. 2007 Jul;2(4):694-9. doi: 10.2215/CJN.01600407. Epub 2007 Jun 6.
8
Tobramycin disposition in the rat lung following airway administration.妥布霉素在气道给药后在大鼠肺部的处置。
J Pharmacol Exp Ther. 2013 Nov;347(2):318-24. doi: 10.1124/jpet.113.207415. Epub 2013 Sep 5.
9
Ototoxicity of tobramycin in humans - influence of renal impairment.
Int J Clin Pharmacol Ther Toxicol. 1982 Sep;20(9):408-16.
10
Tobramycin concentrations during peritoneal dialysis.腹膜透析期间的妥布霉素浓度。
Antimicrob Agents Chemother. 1973 Oct;4(4):432-4. doi: 10.1128/AAC.4.4.432.
本文引用的文献
1
Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study).在间歇性血液透析治疗开始时给予妥布霉素的药代动力学（终末期肾病研究）。
Can J Kidney Health Dis. 2021 Feb 19;8:2054358120987061. doi: 10.1177/2054358120987061. eCollection 2021.
2
Aminoglycosides administration at the end of the hemodialysis session: A pharmacokinetic failure?
Int J Clin Pharmacol Ther. 2020 Jul;58(7):404-405. doi: 10.5414/CP203732.
3
Efficacy and safety of high-dose gentamicin re-dosing in ICU patients receiving haemodialysis.接受血液透析的重症监护病房患者大剂量庆大霉素再次给药的疗效与安全性
J Antimicrob Chemother. 2015 Jan;70(1):308-10. doi: 10.1093/jac/dku369. Epub 2014 Sep 19.
4
Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered.血液透析危重症患者使用庆大霉素：应考虑在给予高剂量后早期进行透析。
Antimicrob Agents Chemother. 2013 Feb;57(2):977-82. doi: 10.1128/AAC.01762-12. Epub 2012 Dec 10.
5
Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen.
Clin J Am Soc Nephrol. 2007 Jul;2(4):694-9. doi: 10.2215/CJN.01600407. Epub 2007 Jun 6.
6
Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.接受血液透析的终末期肾病患者的庆大霉素给药
J Clin Pharmacol. 2006 Nov;46(11):1259-67. doi: 10.1177/0091270006292987.
7
Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.间歇性血液透析中的氨基糖苷类药物：个体化给药的药代动力学
Ann Pharmacother. 2006 Jan;40(1):9-14. doi: 10.1345/aph.1G064. Epub 2005 Dec 6.
Zotero 插件